CALT Annual Accounts Receivable
$17.97 M
+$10.42 M+137.96%
31 December 2023
Summary:
As of February 4, 2025, CALT annual accounts receivable is $17.97 million, with the most recent change of +$10.42 million (+137.96%) on December 31, 2023.CALT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALT Quarterly Accounts Receivable
$20.97 M
+$3.81 M+22.21%
30 June 2024
Summary:
As of February 4, 2025, CALT quarterly accounts receivable is $20.97 million, with the most recent change of +$3.81 million (+22.21%) on June 30, 2024. Over the past year, it has increased by +$3.81 million (+22.21%).CALT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALT Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +138.0% | +22.2% |
| 3 y3 years | - | +2960.8% |
| 5 y5 years | +100.0% | - |
CALT Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Calliditas Therapeutics AB (Publ) Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $20.97 M(+22.2%) |
| Mar 2024 | - | $17.16 M(-4.5%) |
| Dec 2023 | $17.97 M(+138.0%) | $17.97 M(+50.3%) |
| Sept 2023 | - | $11.96 M(-11.3%) |
| June 2023 | - | $13.48 M(+78.5%) |
| Dec 2022 | $7.55 M | $7.55 M(-52.4%) |
| Sept 2022 | - | $15.88 M(+325.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $3.73 M(+444.2%) |
| Mar 2022 | - | $685.20 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $4.99 M(>+9900.0%) | $4.99 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Calliditas Therapeutics AB (publ) annual accounts receivable?
- What is the all time high annual accounts receivable for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) annual accounts receivable year-on-year change?
- What is Calliditas Therapeutics AB (publ) quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) quarterly accounts receivable year-on-year change?
What is Calliditas Therapeutics AB (publ) annual accounts receivable?
The current annual accounts receivable of CALT is $17.97 M
What is the all time high annual accounts receivable for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high annual accounts receivable is $17.97 M
What is Calliditas Therapeutics AB (publ) annual accounts receivable year-on-year change?
Over the past year, CALT annual accounts receivable has changed by +$10.42 M (+137.96%)
What is Calliditas Therapeutics AB (publ) quarterly accounts receivable?
The current quarterly accounts receivable of CALT is $20.97 M
What is the all time high quarterly accounts receivable for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high quarterly accounts receivable is $20.97 M
What is Calliditas Therapeutics AB (publ) quarterly accounts receivable year-on-year change?
Over the past year, CALT quarterly accounts receivable has changed by +$3.81 M (+22.21%)